Larimar Therapeutics, Inc. (LRMR) — SC 13D/A Filings
All SC 13D/A filings from Larimar Therapeutics, Inc.. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (3)
-
Deerfield Ups Larimar Stake to 10.1%
— Mar 15, 2024 Risk: medium
Deerfield Healthcare Innovations Fund, L.P. and its affiliates have amended their Schedule 13D filing regarding Larimar Therapeutics, Inc. as of March 15, 2024. -
Deerfield Amends Larimar Therapeutics Stake
— Feb 16, 2024 Risk: low
Deerfield Management Company, L.P. and its affiliated entities, including Deerfield Healthcare Innovations Fund, L.P., filed an Amendment No. 8 to their Schedul -
Deerfield Management Amends Larimar Therapeutics Stake
— Feb 15, 2024 Risk: medium
Deerfield Management Company, L.P. and its affiliated funds, along with James E. Flynn, filed an Amendment No. 7 to their Schedule 13D on February 15, 2024, reg
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX